Related references
Note: Only part of the references are listed.IL-6 inhibitors for treatment of rheumatoid arthritis: past, present, and future
Go Woon Kim et al.
ARCHIVES OF PHARMACAL RESEARCH (2015)
Novel Serum Biomarkers to Differentiate Cholangiocarcinoma from Benign Biliary Tract Diseases Using a Proteomic Approach
Tavan Janvilisri et al.
DISEASE MARKERS (2015)
Mass spectrometry-based proteomic analysis of formalin-fixed paraffin-embedded extrahepatic cholangiocarcinoma
Shimpei Maeda et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2015)
Heat Shock Protein 90 Is a Potential Therapeutic Target in Cholangiocarcinoma
Tomoki Shirota et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Suppression of Hepatocellular Carcinoma by Inhibition of Overexpressed Ornithine Aminotransferase
Ehud Zigmond et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Molecular pathogenesis of intrahepatic cholangiocarcinoma
Jesper B. Andersen
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2015)
Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implications
Chi Zhang et al.
TUMOR BIOLOGY (2015)
Bile proteomics for differentiation of malignant from benign biliary strictures: a pilot study
Udayakumar Navaneethan et al.
GASTROENTEROLOGY REPORT (2015)
Prognostic parameters in uveal melanoma and their association with BAP1 expression
T. Huibertus van Essen et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2014)
Global Alterations of DNA Methylation in Cholangiocarcinoma Target the Wnt Signaling Pathway
Benjamin Goeppert et al.
HEPATOLOGY (2014)
Regorafenib (BAY 73-4506): Antitumor and antimetastatic activities in preclinical models of colorectal cancer
Roberta Schmieder et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Epithelial-mesenchymal transition phenotypes are associated with patient survival in intrahepatic cholangiocarcinoma
Mi Jin Gu et al.
JOURNAL OF CLINICAL PATHOLOGY (2014)
Cancer biomarker discovery for cholangiocarcinoma: the high-throughput approaches
Atit Silsirivanit et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2014)
High throughput molecular profiling reveals differential mutation patterns in intrahepatic cholangiocarcinomas arising in chronic advanced liver diseases
Sejin Jang et al.
MODERN PATHOLOGY (2014)
Mutation Profiling in Cholangiocarcinoma: Prognostic and Therapeutic Implications
Chaitanya R. Churi et al.
PLOS ONE (2014)
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups
Michele Simbolo et al.
ONCOTARGET (2014)
Integrated Genomic Characterization Reveals Novel, Therapeutically Relevant Drug Targets in FGFR and EGFR Pathways in Sporadic Intrahepatic Cholangiocarcinoma
Mitesh J. Borad et al.
PLOS GENETICS (2014)
Gene Expression Profiling of Intrahepatic Cholangiocarcinoma
Ittisak Subrungruang et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Gene expression-based chemical genomics identifies heat-shock protein 90 inhibitors as potential therapeutic drugs in cholangiocarcinoma
Ming-Huang Chen et al.
CANCER (2013)
Aberrant DNA Methylation at Genes Associated with a Stem Cell-like Phenotype in Cholangiocarcinoma Tumors
Ruethairat Sriraksa et al.
CANCER PREVENTION RESEARCH (2013)
Therapeutic Effects of Deleting Cancer-Associated Fibroblasts in Cholangiocarcinoma
Joachim C. Mertens et al.
CANCER RESEARCH (2013)
Potent in vivo pharmacology of AZD9150, a next-generation, constrained ethyl-modified antisense oligonucleotide targeting STAT3 in multiple preclinical cancer models.
Youngsoo Kim et al.
CANCER RESEARCH (2013)
CA-S27: A novel Lewis a associated carbohydrate epitope is diagnostic and prognostic for cholangiocarcinoma
Atit Silsirivanit et al.
CANCER SCIENCE (2013)
miR-204 Inhibits Epithelial to Mesenchymal Transition by Targeting Slug in Intrahepatic Cholangiocarcinoma Cells
Ying-he Qiu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2013)
Gene expression patterns combined with bioinformatics analysis identify genes associated with cholangiocarcinoma
Li Chen et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2013)
Integrative Molecular Analysis of Intrahepatic Cholangiocarcinoma Reveals 2 Classes That Have Different Outcomes
Daniela Sia et al.
GASTROENTEROLOGY (2013)
Novel genes that mediate nuclear respiratory factor 1-regualted neurite outgrowth in neuroblastoma IMR-32 cells
Chih-Wei Tong et al.
GENE (2013)
A Prospective Proteomic-Based Study for Identifying Potential Biomarkers for the Diagnosis of Cholangiocarcinoma
Yuan Shi et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2013)
Evaluation of regorafenib in colorectal cancer and GIST
Tom Waddell et al.
LANCET (2013)
Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers
Waraporn Chan-on et al.
NATURE GENETICS (2013)
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas
Yuchen Jiao et al.
NATURE GENETICS (2013)
Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas
P. Wang et al.
ONCOGENE (2013)
Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies
D. Sia et al.
ONCOGENE (2013)
Increased bisecting N-acetylglucosamine and decreased branched chain glycans of N-linked glycoproteins in expressed prostatic secretions associated with prostate cancer progression
Julius O. Nyalwidhe et al.
PROTEOMICS CLINICAL APPLICATIONS (2013)
An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells
Dan Rohle et al.
SCIENCE (2013)
Targeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular Differentiation
Fang Wang et al.
SCIENCE (2013)
A novel STAT inhibitor, OPB-31121, has a significant antitumor effect on leukemia with STAT-addictive oncokinases
F. Hayakawa et al.
BLOOD CANCER JOURNAL (2013)
Heparan Sulfate and Heparanase as Modulators of Breast Cancer Progression
Angelica M. Gomes et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Inactivation of Smad4 is a prognostic factor in intrahepatic cholangiocarcinoma
Yan Xue-qiang et al.
CHINESE MEDICAL JOURNAL (2013)
The Clinicopathological and Prognostic Impact of 14-3-3 Protein Isoforms Expression in Human Cholangiocarcinoma by Immunohistochemistry
Qiao Wu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
KrasG12D and p53 Mutation Cause Primary intrahepatic Cholangiocarcinoma
Michael R. O'Dell et al.
CANCER RESEARCH (2012)
被撤回的出版物: Proteomics-based identification of α-enolase as a potential prognostic marker in cholangiocarcinoma (Retracted article. See vol. 49, pg. 196, 2016)
Ponlapat Yonglitthipagon et al.
CLINICAL BIOCHEMISTRY (2012)
Genetic profiling of intrahepatic cholangiocarcinoma
Jesper B. Andersen et al.
CURRENT OPINION IN GASTROENTEROLOGY (2012)
Inflammation-induced protein carbonylation contributes to poor prognosis for cholangiocarcinoma
Raynoo Thanan et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
MicroRNAs in Liver Disease
Xin Wei Wang et al.
GASTROENTEROLOGY (2012)
Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase Inhibitors
Jesper B. Andersen et al.
GASTROENTEROLOGY (2012)
Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma
Naoki Oishi et al.
HEPATOLOGY (2012)
Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma
Benjamin R. Kipp et al.
HUMAN PATHOLOGY (2012)
Exome sequencing of liver fluke-associated cholangiocarcinoma
Choon Kiat Ong et al.
NATURE GENETICS (2012)
Frequent Mutation of Isocitrate Dehydrogenase (IDH)1 and IDH2 in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping
Darrell R. Borger et al.
ONCOLOGIST (2012)
Down-Regulated Expression of HSP70 in Correlation with Clinicopathology of Cholangiocarcinoma
Sirintip Boonjaraspinyo et al.
PATHOLOGY & ONCOLOGY RESEARCH (2012)
Signaling in Control of Cell Growth and Metabolism
Patrick S. Ward et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
Cancer Cell Metabolism: One Hallmark, Many Faces
Jason R. Cantor et al.
CANCER DISCOVERY (2012)
State of Serum Markers for Detection of Cholangiocarcinoma
Sopit Wongkham et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Biochemical characterization of human HIF hydroxylases using HIF protein substrates that contain all three hydroxylation sites
Melissa B. Pappalardi et al.
BIOCHEMICAL JOURNAL (2011)
KRAS and PIK3CA but not BRAF genes are frequently mutated in Chinese cholangiocarcinoma patients
Rui Feng Xu et al.
BIOMEDICINE & PHARMACOTHERAPY (2011)
Genome-wide expression patterns associated with oncogenesis and sarcomatous transdifferentation of cholangiocarcinoma
Min-A Seol et al.
BMC CANCER (2011)
Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma
Vikram Deshpande et al.
BMC CANCER (2011)
A combination of serum leucine-rich α-2-glycoprotein 1, CA 19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary strictures
N. S. Sandanayake et al.
BRITISH JOURNAL OF CANCER (2011)
Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma
M. Miyamoto et al.
BRITISH JOURNAL OF CANCER (2011)
Lactate: A Metabolic Key Player in Cancer
Franziska Hirschhaeuser et al.
CANCER RESEARCH (2011)
p53 Status and Its Prognostic Role in Extrahepatic Bile Duct Cancer: A Meta-Analysis of Published Studies
Juan Wang et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
The Clinical Utility and Limitations of Serum Carbohydrate Antigen (CA19-9) as a Diagnostic Tool for Pancreatic Cancer and Cholangiocarcinoma
Sundeep Singh et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
Metabolic Syndrome Increases the Risk of Primary Liver Cancer in the United States: A Study in the SEER-Medicare Database
Tania M. Welzel et al.
HEPATOLOGY (2011)
Bile Proteomic Profiles Differentiate Cholangiocarcinoma from Primary Sclerosing Cholangitis and Choledocholithiasis
Tim O. Lankisch et al.
HEPATOLOGY (2011)
Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity
Scott M. Wilhelm et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
New Insights into Molecular Mechanisms of Sunitinib-Associated Side Effects
Guadalupe Aparicio-Gallego et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Targeting cancer metabolism: a therapeutic window opens
Matthew G. Vander Heiden
NATURE REVIEWS DRUG DISCOVERY (2011)
Candidate genes involving in tumorigenesis of cholangiocarcinoma induced by Opisthorchis viverrini infection
Zhiliang Wu et al.
PARASITOLOGY RESEARCH (2011)
Trefoil factors: Tumor progression markers and mitogens via EGFR/MAPK activation in cholangiocarcinoma
Kanuengnuch Kosriwong et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Array comparative genomic hybridization identifies novel potential therapeutic targets in cholangiocarcinoma
Siobhan C. McKay et al.
HPB (2011)
Tocilizumab: A new anti-rheumatic drug
Hisham S. Abou-Auda et al.
SAUDI PHARMACEUTICAL JOURNAL (2011)
Proteomic Analysis of Differentially Expressed Proteins in Peripheral Cholangiocarcinoma
Ian A. Darby et al.
CANCER MICROENVIRONMENT (2011)
'Omic' technologies: genomics, transcriptomics, proteomics and metabolomics
Richard P. Horgan et al.
OBSTETRICIAN & GYNAECOLOGIST (2011)
14-3-3 Binding Sites in the Snail Protein Are Essential for Snail-Mediated Transcriptional Repression and Epithelial-Mesenchymal Differentiation
Zhaoyuan Hou et al.
CANCER RESEARCH (2010)
FOXC1 Is a Potential Prognostic Biomarker with Functional Significance in Basal-like Breast Cancer
Partha S. Ray et al.
CANCER RESEARCH (2010)
Differential gene expression profiling of cultured neu-transformed versus spontaneously-transformed rat cholangiocytes and of corresponding cholangiocarcinomas
Catherine I. Dumur et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2010)
Platelet-derived growth factor receptor tyrosine kinase inhibitors: a review of the recent patent literature
Yujia Dai
EXPERT OPINION ON THERAPEUTIC PATENTS (2010)
The clinical potential of microRNAs
Anuradha Budhu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2010)
Comparison of KRAS Mutation Analysis and FISH for Detecting Pancreatobiliary Tract Cancer in Cytology Specimens Collected During Endoscopic Retrograde Cholangiopancreatography
Benjamin R. Kipp et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2010)
Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker
Kusumawadee Utispan et al.
MOLECULAR CANCER (2010)
Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas
J. William Harbour et al.
SCIENCE (2010)
Liver transplantation for cholangiocarcinoma
Charles B. Rosen et al.
TRANSPLANT INTERNATIONAL (2010)
Metabolic profiling of bile in cholangiocarcinoma using in vitro magnetic resonance spectroscopy
Amar W. Sharif et al.
HPB (2010)
Sunitinib A Multitargeted Receptor Tyrosine Kinase Inhibitor in the Era of Molecular Cancer Therapies
Georgios S. Papaetis et al.
BIODRUGS (2009)
Vandetanib (ZD6474), an inhibitor of VEGFR and EGFR signalling, as a novel molecular-targeted therapy against cholangiocarcinoma
D. Yoshikawa et al.
BRITISH JOURNAL OF CANCER (2009)
PIK3CA Mutations Are Not a Major Determinant of Resistance to the Epidermal Growth Factor Receptor Inhibitor Cetuximab in Metastatic Colorectal Cancer
Hans Prenen et al.
CLINICAL CANCER RESEARCH (2009)
Mutations and Response to Epidermal Growth Factor Receptor Inhibitors
Pierre Laurent-Puig et al.
CLINICAL CANCER RESEARCH (2009)
Genetic and expression alterations in association with the sarcomatous change of cholangiocarcinoma cells
Hee-Jung Yoo et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2009)
A Multivariable Model Using Advanced Cytologic Methods for the Evaluation of Indeterminate Pancreatobiliary Strictures
Emily G. Barr Fritcher et al.
GASTROENTEROLOGY (2009)
Burden of Digestive Diseases in the United States Part III: Liver, Biliary Tract, and Pancreas
James E. Everhart et al.
GASTROENTEROLOGY (2009)
MicroRNA-21 Is Overexpressed in Human Cholangiocarcinoma and Regulates Programmed Cell Death 4 and Tissue Inhibitor of Metalloproteinase 3
Florin M. Selaru et al.
HEPATOLOGY (2009)
Pattern of chromosomal aberrations in primary liver cancers identified by comparative genomic hybridization
Kia Homayounfar et al.
HUMAN PATHOLOGY (2009)
Genome wide analysis and clinical correlation of chromosomal and transcriptional mutations in cancers of the biliary tract
George Miller et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2009)
The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma
Lei Chen et al.
JOURNAL OF HEPATOLOGY (2009)
Differential LC-MS-Based Proteomics of Surgical Human Cholangiocarcinoma Tissues
Hiroshi Kawase et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Proteomic Analysis of Human Bile from Malignant Biliary Stenosis Induced by Pancreatic Cancer
Annarita Farina et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Epigenetic alterations associated with cholangiocarcinoma (Review)
Hajime Isomoto
ONCOLOGY REPORTS (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
EGFR and HER2 expression in advanced biliary tract cancer
Jan Harder et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
MicroRNA Profiling of Human Intrahepatic Cholangiocarcinoma Cell Lines Reveals Biliary Epithelial Cell-specific MicroRNAs
Yutaka Kawahigashi et al.
JOURNAL OF NIPPON MEDICAL SCHOOL (2009)
Mucins in cancer: function, prognosis and therapy
Donald W. Kufe
NATURE REVIEWS CANCER (2009)
Detection of cholangiocarcinoma with magnetic resonance spectroscopy of bile in patients with and without primary sclerosing cholangitis
N. Albiin et al.
ACTA RADIOLOGICA (2008)
Cancer cell metabolism: Warburg and beyond
Peggy P. Hsu et al.
CELL (2008)
Cholangiocarcinoma: lessons from Thailand
Banchob Sripa et al.
CURRENT OPINION IN GASTROENTEROLOGY (2008)
Rare PIK3CA hotspot mutations in carcinomas of the biliary tract
Marc-Oliver Riener et al.
GENES CHROMOSOMES & CANCER (2008)
Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment
Boris Blechacz et al.
HEPATOLOGY (2008)
Expression of matrix metalloproteinose 7 is an unfavorable postoperative prognostic factor in cholongiocarcinoma of the perihilar, hilar, and extrahepatic bile ducts
Keita Itatsu et al.
HUMAN PATHOLOGY (2008)
Glycine N-methyltransferase is a favorable prognostic marker for human cholangiocarcinoma
Yu-Chuen Huang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
EWS/FLI Mediates Transcriptional Repression via NKX2.2 during Oncogenic Transformation in Ewing's Sarcoma
Leah A. Owen et al.
PLOS ONE (2008)
Identification of osteopontin as the most consistently over-expressed gene in intrahepatic cholangiocarcinoma: Detection by oligonucleotide microarray and real-time PCR analysis
Holger G. Hass et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
c-Met targeted therapy of cholangiocarcinoma
Matei P. Socoteanu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinoma
Alphonse E. Sirica
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Surgical Outcome and Prognostic Factors in Intrahepatic Cholangiocarcinoma
Toshio Nakagohri et al.
WORLD JOURNAL OF SURGERY (2008)
Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma
D. Yoshikawa et al.
BRITISH JOURNAL OF CANCER (2008)
Gel-forming mucins appeared early in metazoan evolution
Tiange Lang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Mass spectrometry based proteomics in urine biomarker discovery
Dan Theodorescu et al.
WORLD JOURNAL OF UROLOGY (2007)
Expression and prognostic significance of EFNB2 and EphB4 genes in patients with oesophageal squamous cell carcinoma
M. Tachibana et al.
DIGESTIVE AND LIVER DISEASE (2007)
Stromal myofibroblasts predict disease recurrence for colorectal cancer
Tadashi Tsujino et al.
CLINICAL CANCER RESEARCH (2007)
Olfactomedin 4 promotes S-phase transition in proliferation of pancreatic cancer cells
Daisuke Kobayashi et al.
CANCER SCIENCE (2007)
Emerging roles for zic genes in early development
Christa S. Merzdorf
DEVELOPMENTAL DYNAMICS (2007)
Comprehensive DNA methylation profiling in a human cancer genome identifies novel epigenetic targets
J. M. Ordway et al.
CARCINOGENESIS (2006)
Introduction to NF-κB:: players, pathways, perspectives
T. D. Gilmore
ONCOGENE (2006)
Discovery and development of sorafenib: a multikinase inhibitor for treating cancer
Scott Wilhelm et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease
Justin Lamb et al.
SCIENCE (2006)
Prognostic significance of microsatellite alterations at 1p36 in cholangiocarcinoma
Temduang Limpaiboon et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
A molecular correlate to the Gleason grading system for prostate adenocarcinoma
Lawrence True et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Amplification of chromosome 21q22.3 harboring trefoil factor family genes in liver fluke related cholangiocarcinoma is associated with poor prognosis
Kanuengnuch Muenphon et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Identification of intrahepatic cholangiocarcinoma related genes by comparison with normal liver tissues using expressed sequence tags
Ai-Guo Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Review article: the modern diagnosis and therapy of cholangiocarcinoma
H Malhi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Autoproteolysis coupled to protein folding in the SEA domain of the membrane-bound MUC1 mucin
B Macao et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2006)
erbB-2/neu transformed rat cholangiocytes recapitulate key cellular and molecular features of human bile duct cancer
GH Lai et al.
GASTROENTEROLOGY (2005)
Glycochenodeoxycholate plays a carcinogenic role in immortalized mouse cholanglocytes via oxidative DNA damage
D Komichi et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
Interleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholanglocarcinoma cells
H Isomoto et al.
HEPATOLOGY (2005)
Detection of response-predicting mutations in the kinase domain of the epidermal growth factor receptor gene in cholangiocarcinomas
GY Gwak et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2005)
The MUC1 SEA module is a self-cleaving domain
F Levitin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
MUC1 and MUC5AC mucin expression in liver fluke-associated intrahepatic cholangiocarcinoma
Chanchai Boonla et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Foxc1 integrates Fgf and Bmp signalling independently of twist or Noggin during calvarial bone development
R Rice et al.
DEVELOPMENTAL DYNAMICS (2005)
Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers
K Nakazawa et al.
JOURNAL OF PATHOLOGY (2005)
DJ-1, a novel regulator of the tumor suppressor PTEN
RH Kim et al.
CANCER CELL (2005)
A small molecule-kinase interaction map for clinical kinase inhibitors
MA Fabian et al.
NATURE BIOTECHNOLOGY (2005)
Chromosomal imbalances in Korean intrahepatic cholangiocarcinoma by comparative genomic hybridization
KO Uhm et al.
CANCER GENETICS AND CYTOGENETICS (2005)
Proteomic analysis of cholangiocarcinoma cell line
C Srisomsap et al.
PROTEOMICS (2004)
MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type
H Shibahara et al.
HEPATOLOGY (2004)
Genetic alterations in intrahepatic cholangiocarcinoma as revealed by degenerate oligonucleotide primed PCR-comparative genomic hybridization
JY Lee et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2004)
The epidemiology of cholangiocarcinoma
Y Shaib et al.
SEMINARS IN LIVER DISEASE (2004)
Epithelial-mesenchymal transition and its implications for fibrosis
R Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Role of Smad4 (DPC4) inactivation in human cancer
M Miyaki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma
A Tannapfel et al.
GUT (2003)
Cholangiocarcinoma: Current concepts and insights
GJ Gores
HEPATOLOGY (2003)
Clinical outcomes and apomucin expression of intrahepatic cholanglocarcinoma according to gross morphology
KS Suh et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2002)
Expression of MUC1 and MUC2 mucins in extrahepatic bile duct carcinomas: Its relationship with tumor progression and prognosis
S Tamada et al.
PATHOLOGY INTERNATIONAL (2002)
Clinical proteomics: Translating benchside promise into bedside reality
EF Petricoin et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
New insights into the structure and function of fatty acid-binding proteins
AW Zimmerman et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2002)
Correlation between expression of MUC1 core protein and outcome after surgery in mass-forming intrahepatic cholangiocarcinoma
N Matsumura et al.
CANCER (2002)
Matrix metalloproteinase-7 expression and biologic aggressiveness of cholangiocellular carcinoma
S Miwa et al.
CANCER (2002)
Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis
E Steels et al.
EUROPEAN RESPIRATORY JOURNAL (2001)
Genetic alterations in hepatocellular carcinoma and intrahepatic cholangiocarcinoma
SH Koo et al.
CANCER GENETICS AND CYTOGENETICS (2001)
Role of the iroquois3 homeobox gene in organizer formation
T Kudoh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Increased expression of S100A6 at the invading fronts of the primary lesion and liver metastasis in patients with colorectal adenocarcinoma
K Komatsu et al.
BRITISH JOURNAL OF CANCER (2000)
Share Paper
